Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 01 2020
Historique:
pubmed: 5 11 2019
medline: 29 6 2021
entrez: 5 11 2019
Statut: ppublish

Résumé

Childhood stress exposure is associated with inflammation as measured by C-reactive protein (CRP) and interleukin 6 (IL-6). However, findings are inconsistent and effect sizes are small. The addition of soluble urokinase plasminogen activator receptor (suPAR), a new biomarker of chronic inflammation, may improve measurement of stress-related inflammatory burden. To assess whether exposure to adverse experiences, stress, and violence is associated with an increase in suPAR levels in young people and to test the hypothesis that measuring suPAR in addition to CRP or IL-6 levels improves the assessment of the inflammatory burden associated with early-life stress. This cohort study included 1391 participants from a 1994 to 1995 birth cohort of twins from the nationally representative Environmental Risk Longitudinal Twin Study in the United Kingdom. Participants were followed up until 18 years of age (93% retention). Plasma samples were analyzed in July 2018, and statistical analysis was performed from October 1, 2018, to May 31, 2019. Adverse childhood experiences and childhood and adolescent experience of stress and violence exposure. Plasma CRP, IL-6, and suPAR levels at 18 years of age. Among 1391 young people (mean [SD] age, 18.4 [0.36] years; 733 [52.7%] female), those who had been exposed to stressful experiences had elevated suPAR levels by 18 years of age after controlling for sex, body mass index, and smoking: 0.03-ng/mL (95% CI, 0.01-0.05 ng/mL) increase in suPAR per each additional adverse childhood experience, 0.09-ng/mL (95% CI, 0.01-0.17 ng/mL) increase in suPAR per each additional severe childhood experience of stress or violence, and 0.04-ng/mL (95% CI, -0.02 to 0.10 ng/mL) increase in suPAR per each additional severe adolescent experience of stress or violence. Individuals exposed to multiple types of violence in both childhood and adolescence had 0.26-ng/mL (95% CI, 0.07-0.45 ng/mL) higher suPAR levels compared with children who did not experience stress or violence. These stress-exposed young people were significantly more likely to have elevated suPAR levels at 18 years of age even if they did not have elevated CRP or IL-6 levels. Measuring suPAR in addition to CRP or IL-6 increased the association between stress exposure and inflammatory burden. For example, after adjusting for CRP and IL-6 levels, each additional adverse childhood experience was associated with a 0.05-mL (95% CI, 0.03-0.07 ng/mL) increase in suPAR, each additional severe childhood experience of stress or violence was associated with a 0.14-ng/mL (95% CI, 0.06-0.22 ng/mL) increase in suPAR, and each additional severe adolescent experience of stress or violence was associated with a 0.10-ng/mL (95% CI, 0.04-0.16 ng/mL) increase in suPAR. The results suggest that adult inflammation is associated with childhood exposure to stress. Adding information about suPAR to traditional biomarkers of inflammation may improve the measurement of inflammatory burden associated with exposure to stress and violence.

Identifiants

pubmed: 31682707
pii: 2754102
doi: 10.1001/jamapediatrics.2019.3875
pmc: PMC6830440
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Twin Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-47

Subventions

Organisme : Medical Research Council
ID : G1002190
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005918/1
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : P2C HD065563
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032282
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Line Jee Hartmann Rasmussen (LJH)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
Clinical Research Centre, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.

Terrie E Moffitt (TE)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.
Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

Louise Arseneault (L)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

Andrea Danese (A)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
National and Specialist Child and Adolescent Mental Health Services Trauma, Anxiety, and Depression Clinic, South London and Maudsley National Health Service Foundation Trust, London, United Kingdom.

Jesper Eugen-Olsen (J)

Clinical Research Centre, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.

Helen L Fisher (HL)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

HonaLee Harrington (H)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.

Renate Houts (R)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.

Timothy Matthews (T)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

Karen Sugden (K)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.

Benjamin Williams (B)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.

Avshalom Caspi (A)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.
Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH